ARK Genomic Revolution ET... (ARKG)
Cboe US: ARKG
· Prix en temps réel · USD
49.45
+1.81 (3.80%)
À la clôture : Aug 21, 2026, 3:59 PM
ARK Genomic Revolution ETF (ARKG) : cours, positions et analyse de l'ETF
3.80% (1D)
| Bid | 49.45 |
| Capitalisation boursière | n/a |
| AUM | 1.56B |
| NAV | 49.49 |
| Bêta | 2.38 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | n / A |
| Parts en circulation | n / A |
| Date de création | Oct 31, 2014 |
| Ask | 49.65 |
| Volume | 9,996,524 |
| Moy. Volume (20D) | 3,542,880 |
| Ouverture | 47.93 |
| Clôture précédente | 47.64 |
| Fourchette du jour | 47.55 - 49.56 |
| Intervalle de 52 semaines | 24.20 - 49.56 |
| Positions | n / A |
| Ratio de frais | 0.75% |
À propos de ARKG
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Classe d’actifs Equity
Symbole boursier ARKG
Date de création Oct 31, 2014
Fournisseur Ark Etf Trust
Site web Page d’accueil du fonds
Échange Cboe US
10 principaux titres 59.15% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| 10x Genomics Inc Ord... | TXG | 9.41% |
| Twist Bioscience Cor... | TWST | 7.74% |
| Tempus Ai Inc Class ... | TEM | 6.57% |
| Crispr Therapeutics ... | CRSP | 6.30% |
| Personalis Inc | PSNL | 5.48% |
| Absci Corp | ABSI | 5.15% |
| Guardant Health Inc | GH | 4.75% |
| Illumina Inc | ILMN | 4.75% |
| Eli Lilly And Co | LLY | 4.69% |
| Caredx Inc | CDNA | 4.31% |
Dividendes Rendement du dividende 0.77%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 29, 2021 | $0.3820 | n / A |
| Dec 29, 2020 | $0.7900 | n / A |
| Dec 27, 2019 | $1.0540 | n / A |
| Dec 27, 2018 | $0.4660 | n / A |
| Dec 27, 2017 | $0.3280 | n / A |
